CBLI Gets BioTech ExposureCBLI Cited Sunday July 01,in a BioHealthInvestor.com "Interview: Investment Opportunities in Healthcare with Alan Brochstein". Alan Brochstein is a CFA with AB Analytical Services.
In responding to a question, he noted, "I created a universe of stocks today with all of the U.S. based biotechs with market capitalization in excess of $50mm. It is clear why so many investors are attracted to the market, as the payoffs can be quite extreme. In fact, thus far this year, nine companies have gained in excess of 75%, including Opko Health (OPK), Celsion (CLN), Bionovo (BNVI), Onyx (ONXX), BioSante (BPA), Clevland Biolabs (CBLI), Seattle Genetics (SGEN), Biopure (BPUR) and the infamous Dendreon (DNDN)."